Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories.

Hawser, Stephen; Kothari, Nimmi; Jemmely, Noëlle; Redder, Nowel

Hawser, Stephen; Kothari, Nimmi; Jemmely, Noëlle; Redder, Nowel.

Afiliação

Hawser S; IHMA Europe Sàrl, Monthey, Switzerland. Electronic address: shawser@ihmainc.com.
Kothari N; IHMA Europe Sàrl, Monthey, Switzerland.
Jemmely N; Advanz Pharma Switzerland Sàrl, Geneva, Switzerland.
Redder N; Advanz Pharma Switzerland Sàrl, Geneva, Switzerland.

J Glob Antimicrob Resist ; 29: 393-397, 2022 06.

Article em En | MEDLINE | ID: mdl-35561977

Assuntos

Antibacterianos; Cefalosporinas; Antibacterianos/farmacologia; Cefalosporinas/farmacologia; Testes de Sensibilidade Microbiana; Staphylococcus aureus

Palavras-chave

Ceftobiprole; Europe; Susceptibility

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cefalosporinas / Antibacterianos Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google